Skip to content
ECPC - European Cancer Patient Coalition
Contact
  • Policy
    • Innovation
      • Access to Medicines
      • Europe of Disparities in Cancer Care
      • Molecular Testing & Personalised Medicine
      • Biosimilars
      • Immuno-Oncology
    • Health Technology Assessment
      • HTA Legislation
    • Public Health Policies
      • European Partnership for Action Against Cancer (EPAAC)
      • Joint Action on Cancer Control (CanCon)
      • iPAAC
      • Vaccines
      • Brexit
    • Societal Issues
      • Cancer Patients’ Rights
      • Employment
      • Survivorship
      • Carers
      • Right to Be Forgotten
    • Quality of Care
      • Cancer Comorbidities
      • All.Can
      • BenchCan
      • Nutrition
      • Specific Cancers
    • Rare Cancers
      • JARC
      • EURACAN
      • RARECARENet
  • Health and Research
    • European Policy Initiatives
      • 4.UNCAN.eu
      • CanSERV
      • CCI4EU
      • EOSC4Cancer
      • Smart Care
    • Big Data and Personalised Medicine
      • BD4BO PIONEER
      • COMFORT
      • LEGACy
      • Instand-NGS4P
      • INTERVENE
      • T2EVOLVE
      • QUALITOP
      • TIGER
      • OPTIMA
      • AIDAVA
      • CGI-Clinics
      • Lifechamps
    • Patients and Caregivers
      • DIAdIC
      • MyPath
      • PREFERABLE-II
      • RELEVIUM
    • Palliative Care
      • Palliative Sedation
      • Painless
      • INSPIRE
      • Pal-Cycles
    • Treatments
      • Immune-Image
      • ImmunoSABR
      • SALVOVAR
    • Digital Health
      • XpandDH
      • Transition
    • Imaging
      • Imagio
      • IDERHA
    • Prevention
      • ONCODIR
    • Past Projects
      • BD4BO DO-IT
      • DENIM
      • eSMART
      • EUCANCan
      • PREDICT
      • PREFER
  • Get Involved
    • Membership
    • Campaigns
      • Bladder Cancer Awareness Month Campaign
      • Head and Neck Cancer Campaigns 2021
      • Nutrition and Physical Activity
      • Pancreatic Cancer ‘World Pancreatic Cancer Day’ Campaign
      • Personalised Medicine Awareness Month
      • Non Melanoma Skin Cancer Campaign
      • Merkel Cell Carcinoma Awareness Campaign
      • Merkel Cell Carcinoma 2020 Awareness Campaign
      • Breast Cancer
    • Working Groups
      • Rare Cancers Working Group
      • Urological Cancer Working Group
      • The Legal Network for Cancer Patients
    • Partnerships
      • Funding Policy and Good Practices
      • European Medicines Agency
      • Collaborations
      • Graphic Design Kit
    • Industry Supporters
  • TOOLBOX
    • Tools
      • Biobanking
      • Bone Health
      • Clinical Trials Database
      • ESMO Cancer Patient Guides
      • Nutrition Booklet
      • The Immuno-oncology Portal (IOP)
      • Personalised Medicine
      • Non-Melanoma Skin Cancer Web Hub
      • Merkel Cell Carcinoma
      • Cancer Associated Thrombosis (CAT)
      • Health Technology Assessment E-Module
      • Social Media Manual, Cancer Advocacy Academy
      • Biosimilars E-module
      • Genetics and Genomics Testing – A guide for patients E-module
    • References
      • White Papers
      • EU Funded Programmes
    • Publications
    • Resources
  • News and Events
    • News
    • Elections
    • Conference and General Meeting
      • Invitation to Annual Congress 2023
    • Events
    • Newsletters
  • About us
    • Our Strategy
    • Our Team
    • Members
    • Vacancies
    • Our History
    • Mission and Vision
    • Transparency
  • Intergroup
Contact

Projects

English

“Nothing about us without us!” ECPC 

The European Cancer Patient Coalition (ECPC) works for a Europe of equality, where all European cancer patients have timely and affordableaccess to the best treatment and care available, throughout their life. ECPC believes that cancer patients are the most important partners in the fight against cancer and against all the cancer-related issues affecting our society. Policy makers, researchers, doctors and industry should recognise cancer patients as co-creators of their own health.

The European cancer patient Coalition participates in several European Union’s Research and Innovation framework programmes, among others: this includes IMI 1 projects, the Seventh Framework Programme (FP7), and IMI 2 projects under the current Horizon 2020 (H2020).

– European Added Value

ECPC’s participation in calls look into the basic principle of incooporating European added value to current Members’ activities. The European Commission defines European added value, under the 3rd Health Programme, as “additional to the value created by actions of individual Member States. It may result from different factors, e.g. coordination gains, legal certainty, greater effectiveness or complementarities. It reflects broader European relevance and significance of the action with a view to presenting models and mechanisms which can be applied not only regionally or nationally but also EU widely.”

– ECPC in Research

ECPC is one of the few patients organisations directly involved in research. The European Cancer Patient Coalition draws on fundamental knowledge and understanding of the patients’ situation by working through our Members. Its “on the field” engagement enhances ECPC’s capacity to truly represent patients at the EU level, providing irreplaceable first-hand understanding of the issues revolving around cancer patients. Furthermore, EU funded research projects allow us to be on the forefront of scientific developments on cancer by providing the patient’s perspective while draining fundamental knowledge on the science behind cancer.

< Back to News

Donate

x

The fight against cancer is not just for patients, it is vital that we work together.

Your support is greatly appreciated!  Donate now

What happens to your donation?

We understand that when you make a donation, you want to know exactly what happens to your money. We aim to be clear and transparent when it comes to using your contributions in our mission to fight cancer. Your donations not only help us to empower the cancer patient community and make a positive difference to healthcare, treatment and accessibility, but also enable us to:
  • ensure our members are engaged and feel part of an active community through information, training, unique resources, tools, opportunities and networking at a national and European level
  • legitimise our position of cancer patient representatives before decision-makers
  • build a reputation as a cancer patient expert within the scientific community
  • find partners sharing the same vision, values and goals to work together on projects
  • get the media’s attention in order to publish and disseminate our messages
  • make the general public aware and supportive

Subscribe to our newsletter

x

Subscribe

* indicates required

By clicking on the button below I expressly confirm that I have read and understood ECPC Privacy Policy http://ow.ly/i94050BPZx0

For more information on ECPC's policies visit our website http://ow.ly/8XCj50BQasP

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Connect with us

English

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Youtube

© ECPC 2025. All rights reserved.

  • Privacy Policy
  • Terms & Conditions
  • Cookie Policy of the of ECPC AISBL
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkCookie policy